175 related articles for article (PubMed ID: 10853811)
21. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
[TBL] [Abstract][Full Text] [Related]
22. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB
Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363
[TBL] [Abstract][Full Text] [Related]
23. Influence of size of regions of interest on the measurement of uptake of 123I-alpha-methyl tyrosine by brain tumours.
Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Schäfers M; Wassmann H; Schober O
Nucl Med Commun; 1996 Jul; 17(7):609-15. PubMed ID: 8843121
[TBL] [Abstract][Full Text] [Related]
24. I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours.
Matheja P; Weckesser M; Rickert Ch; Franzius Ch; Palkovic S; Riemann B; Schober O
Nuklearmedizin; 2002; 41(4):191-6. PubMed ID: 12224403
[TBL] [Abstract][Full Text] [Related]
25. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT.
Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E; Rosén I
J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):569-74. PubMed ID: 9408094
[TBL] [Abstract][Full Text] [Related]
27. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Stokkel M; Stevens H; Taphoorn M; Van Rijk P
Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
[TBL] [Abstract][Full Text] [Related]
28. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
[TBL] [Abstract][Full Text] [Related]
30. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.
Grosu AL; Feldmann H; Dick S; Dzewas B; Nieder C; Gumprecht H; Frank A; Schwaiger M; Molls M; Weber WA
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):842-54. PubMed ID: 12377338
[TBL] [Abstract][Full Text] [Related]
31. Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours.
Gungor F; Bezircioglu H; Guvenç G; Tezcan M; Yildiz A; Uluc E; Isisag A
Nucl Med Commun; 2000 Sep; 21(9):803-10. PubMed ID: 11065152
[TBL] [Abstract][Full Text] [Related]
32. 123I-IMP SPET in the diagnosis of primary central nervous system lymphoma.
Yoshikai T; Fukahori T; Ishimaru J; Kato A; Uchino A; Tabuchi K; Kudo S
Eur J Nucl Med; 2001 Jan; 28(1):25-32. PubMed ID: 11202448
[TBL] [Abstract][Full Text] [Related]
33. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.
Weber WA; Dick S; Reidl G; Dzewas B; Busch R; Feldmann HJ; Molls M; Lumenta CB; Schwaiger M; Grosu AL
J Nucl Med; 2001 Aug; 42(8):1144-50. PubMed ID: 11483672
[TBL] [Abstract][Full Text] [Related]
34. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of malignant glioma and metastatic brain tumor by thallium-201 single photon emission computed tomography.
Kojima Y; Kuwana N; Noji M; Tosa J
Neurol Med Chir (Tokyo); 1994 Sep; 34(9):588-92. PubMed ID: 7526248
[TBL] [Abstract][Full Text] [Related]
36. Early dynamic 201Tl SPECT in the evaluation of brain tumours.
Sugo N; Yokota K; Kondo K; Harada N; Aoki Y; Miyazaki C; Nemoto M; Kano T; Ohishi H; Seiki Y
Nucl Med Commun; 2006 Feb; 27(2):143-9. PubMed ID: 16404227
[TBL] [Abstract][Full Text] [Related]
37. Quantitative 201Tl SPET imaging in the follow-up of treatment for brain tumour: a sensitive tool for the early identification of response to chemotherapy?
Källén K; Geijer B; Malmström P; Andersson AM; Holtås S; Ryding E; Rosén I
Nucl Med Commun; 2000 Mar; 21(3):259-67. PubMed ID: 10823328
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells.
Riemann B; Stögbauer F; Kopka K; Halfter H; Lasic M; Schirmacher A; Kuwert T; Weckesser M; Ringelstein EB; Schober O
Eur J Nucl Med; 1999 Oct; 26(10):1274-8. PubMed ID: 10541825
[TBL] [Abstract][Full Text] [Related]
39. The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment.
Yoshii Y; Satou M; Yamamoto T; Yamada Y; Hyodo A; Nose T; Ishikawa H; Hatakeyama R
Eur J Nucl Med; 1993 Jan; 20(1):39-45. PubMed ID: 8420781
[TBL] [Abstract][Full Text] [Related]
40. Detection of lung lesions and lymph nodes with 201Tl SPET.
Arbab AS; Koizumi K; Toyama K; Arai T; Yoshitomi T; Araki T
Nucl Med Commun; 1998 May; 19(5):411-6. PubMed ID: 9853329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
